Jens Overgaard
Impact in
- Otorhinolaryngology top 0.01%
- Head and Neck Cancer Studies
- Cancer Research top 0.02%
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Head and Neck Cancer Studies 179
- Cancer Research 225
- Cancer, Hypoxia, and Metabolism 124
- Breast Cancer Treatment Studies 90
- Co-authors
- Marie Overgaard (85 shared papers)Michael R. Horsman (116 shared papers)Jan Alsner (115 shared papers)Søren Møller Bentzen (51 shared papers)Marianne Nordsmark (43 shared papers)Cai Grau (92 shared papers)Jørgen Johansen (79 shared papers)Jesper Grau Eriksen (52 shared papers)
- Journals
- Radiotherapy and Oncology (174 papers)Acta Oncologica (151 papers)International Journal of Radiation Oncology*Biology*Physics (64 papers)European Journal of Cancer (30 papers)British Journal of Cancer (25 papers)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Jens Overgaard
735 papers receiving 41.3k citations
Jens Overgaard's Hit Papers
Peers
Comparison fields: 5 of 167
- Otorhinolaryngology 7.6k
- Cancer Research 12.5k
- Radiation 4.2k
- Radiology, Nuclear Medicine and Imaging 6.8k
- Oncology 4.4k
Countries citing papers authored by Jens Overgaard
This map shows the geographic impact of Jens Overgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Overgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Overgaard more than expected).
Fields of papers citing papers by Jens Overgaard
This network shows the impact of papers produced by Jens Overgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Overgaard. The network helps show where Jens Overgaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Jens Overgaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 751 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy Hit paper breakdown → | 1997 | 2100 |
| 2 | Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial Hit paper breakdown → | 1999 | 1319 |
| 3 | Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis Hit paper breakdown → | 2006 | 864 |
| 4 | Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck Hit paper breakdown → | 1996 | 852 |
| 5 | Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Hit paper breakdown → | 2005 | 812 |
| 6 | Radiation oncology in the era of precision medicine Hit paper breakdown → | 2016 | 666 |
| 7 | Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial Hit paper breakdown → | 2003 | 563 |
| 8 | Imaging hypoxia to improve radiotherapy outcome Hit paper breakdown → | 2012 | 542 |
| 9 | 2007 | 519 | |
| 10 | Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck Hit paper breakdown → | 2009 | 518 |
| 11 | 1995 | 489 | |
| 12 | A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85 Hit paper breakdown → | 1998 | 484 |
| 13 | 2008 | 475 | |
| 14 | The current and potential role of hyperthermia in radiotherapy Hit paper breakdown → | 1989 | 442 |
| 15 | 2007 | 397 | |
| 16 | Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysis Hit paper breakdown → | 2011 | 395 |
| 17 | 1996 | 369 | |
| 18 | 2007 | 351 | |
| 19 | 2015 | 350 | |
| 20 | 1980 | 325 |
About Jens Overgaard
Jens Overgaard is a scholar working on Otorhinolaryngology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Radiation and Pulmonary and Respiratory Medicine, having authored 751 papers that have together received 43.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (179 papers), Cancer, Hypoxia, and Metabolism (124 papers), Breast Cancer Treatment Studies (90 papers), Effects of Radiation Exposure (88 papers), Ultrasound and Hyperthermia Applications (85 papers), Radiation Therapy and Dosimetry (80 papers), Advanced Radiotherapy Techniques (61 papers) and Angiogenesis and VEGF in Cancer (23 papers). The work is most often cited by research in Otorhinolaryngology (7.6k citations), Cancer Research (12.5k citations), Radiation (4.2k citations), Radiology, Nuclear Medicine and Imaging (6.8k citations) and Oncology (4.4k citations). Jens Overgaard has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Marie Overgaard, Michael R. Horsman, Jan Alsner, Søren Møller Bentzen, Marianne Nordsmark, Cai Grau, Jørgen Johansen, Jesper Grau Eriksen, Ole Steen Nielsen and Hanne Melgaard Nielsen. Their work appears in journals such as Radiotherapy and Oncology, Acta Oncologica, International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.